Correlation Between Rezolute and Hillstream Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rezolute and Hillstream Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Hillstream Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and Hillstream Biopharma, you can compare the effects of market volatilities on Rezolute and Hillstream Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Hillstream Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Hillstream Biopharma.

Diversification Opportunities for Rezolute and Hillstream Biopharma

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Rezolute and Hillstream is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Hillstream Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillstream Biopharma and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Hillstream Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillstream Biopharma has no effect on the direction of Rezolute i.e., Rezolute and Hillstream Biopharma go up and down completely randomly.

Pair Corralation between Rezolute and Hillstream Biopharma

If you would invest  39.00  in Hillstream Biopharma on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Hillstream Biopharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.76%
ValuesDaily Returns

Rezolute  vs.  Hillstream Biopharma

 Performance 
       Timeline  
Rezolute 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating essential indicators, Rezolute may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Hillstream Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Rezolute and Hillstream Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rezolute and Hillstream Biopharma

The main advantage of trading using opposite Rezolute and Hillstream Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Hillstream Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillstream Biopharma will offset losses from the drop in Hillstream Biopharma's long position.
The idea behind Rezolute and Hillstream Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal